Fresh Tracks Therapeutics (FRTX) Competitors $0.94 -0.01 (-0.53%) As of 02/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock FRTX vs. NAII, PMN, ALLK, UBX, LIAN, BIVI, LSTA, MIRA, CVM, and NNVCShould you be buying Fresh Tracks Therapeutics stock or one of its competitors? The main competitors of Fresh Tracks Therapeutics include Natural Alternatives International (NAII), ProMIS Neurosciences (PMN), Allakos (ALLK), Unity Biotechnology (UBX), LianBio (LIAN), BioVie (BIVI), Lisata Therapeutics (LSTA), MIRA Pharmaceuticals (MIRA), CEL-SCI (CVM), and NanoViricides (NNVC). These companies are all part of the "pharmaceutical products" industry. Fresh Tracks Therapeutics vs. Natural Alternatives International ProMIS Neurosciences Allakos Unity Biotechnology LianBio BioVie Lisata Therapeutics MIRA Pharmaceuticals CEL-SCI NanoViricides Natural Alternatives International (NASDAQ:NAII) and Fresh Tracks Therapeutics (NASDAQ:FRTX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, community ranking, media sentiment and analyst recommendations. Is NAII or FRTX more profitable? Fresh Tracks Therapeutics has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.26%. Fresh Tracks Therapeutics' return on equity of 0.00% beat Natural Alternatives International's return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.26% -9.36% -4.82% Fresh Tracks Therapeutics N/A N/A N/A Do institutionals & insiders hold more shares of NAII or FRTX? 32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 25.0% of Fresh Tracks Therapeutics shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by insiders. Comparatively, 0.2% of Fresh Tracks Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media prefer NAII or FRTX? In the previous week, Natural Alternatives International had 4 more articles in the media than Fresh Tracks Therapeutics. MarketBeat recorded 4 mentions for Natural Alternatives International and 0 mentions for Fresh Tracks Therapeutics. Natural Alternatives International's average media sentiment score of 0.40 beat Fresh Tracks Therapeutics' score of 0.00 indicating that Natural Alternatives International is being referred to more favorably in the media. Company Overall Sentiment Natural Alternatives International Neutral Fresh Tracks Therapeutics Neutral Which has preferable earnings and valuation, NAII or FRTX? Fresh Tracks Therapeutics has lower revenue, but higher earnings than Natural Alternatives International. Natural Alternatives International is trading at a lower price-to-earnings ratio than Fresh Tracks Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$121.85M0.18-$7.22M-$1.29-2.71Fresh Tracks Therapeutics$10.06M0.56-$5.69M-$1.41-0.66 Which has more volatility and risk, NAII or FRTX? Natural Alternatives International has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Fresh Tracks Therapeutics has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500. Does the MarketBeat Community favor NAII or FRTX? Natural Alternatives International received 271 more outperform votes than Fresh Tracks Therapeutics when rated by MarketBeat users. Likewise, 76.55% of users gave Natural Alternatives International an outperform vote while only 0.00% of users gave Fresh Tracks Therapeutics an outperform vote. CompanyUnderperformOutperformNatural Alternatives InternationalOutperform Votes27176.55% Underperform Votes8323.45% Fresh Tracks TherapeuticsOutperform VotesNo VotesUnderperform Votes1100.00% SummaryNatural Alternatives International beats Fresh Tracks Therapeutics on 9 of the 15 factors compared between the two stocks. Remove Ads Get Fresh Tracks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FRTX vs. The Competition Export to ExcelMetricFresh Tracks TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.59M$3.03B$5.63B$7.84BDividend YieldN/A1.55%5.33%4.01%P/E Ratio-0.6629.9323.5518.73Price / Sales0.56431.51388.1990.75Price / CashN/A168.6838.1734.64Price / Book0.563.926.894.23Net Income-$5.69M-$71.95M$3.20B$247.47M7 Day PerformanceN/A-5.68%-3.06%-2.29%1 Month PerformanceN/A-12.09%1.51%-5.81%1 Year Performance3.37%-27.90%9.35%-0.94% Fresh Tracks Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+3.4%$5.59M$10.06M-0.6620NAIINatural Alternatives International0.7608 of 5 stars$3.59-2.7%N/A-42.5%$22.25M$121.85M-2.78290Analyst ForecastShort Interest ↑News CoveragePMNProMIS Neurosciences0.707 of 5 stars$0.66+2.0%N/A-62.0%$21.67MN/A-6.635Short Interest ↑Gap UpALLKAllakos4.6072 of 5 stars$0.24-2.5%$2.00+732.6%-81.7%$21.67MN/A-0.12190Short Interest ↓Positive NewsUBXUnity Biotechnology4.1159 of 5 stars$1.27-2.7%$5.33+321.6%-30.5%$21.34M$240,000.00-0.9760Analyst ForecastAnalyst RevisionLIANLianBioN/A$0.20-2.3%N/A-41.2%$21.12MN/A-0.24110Gap DownBIVIBioVie2.8308 of 5 stars$1.12-5.1%$3.00+167.9%+91.1%$20.67MN/A-0.1110Short Interest ↓News CoverageLSTALisata Therapeutics3.0201 of 5 stars$2.38+1.3%$15.00+530.3%-24.7%$20.52M$1M-0.9530Short Interest ↓Gap DownMIRAMIRA Pharmaceuticals1.9682 of 5 stars$1.22-0.8%$14.00+1,047.5%-3.6%$20.20MN/A-2.182Earnings ReportShort Interest ↑CVMCEL-SCIN/A$0.25-6.1%N/A-87.5%$20.03MN/A-0.5243Analyst ForecastNNVCNanoViricidesN/A$1.28-3.8%N/A+4.3%$20.02MN/A-1.7820News Coverage Remove Ads Related Companies and Tools Related Companies Natural Alternatives International Alternatives ProMIS Neurosciences Alternatives Allakos Alternatives Unity Biotechnology Alternatives LianBio Alternatives BioVie Alternatives Lisata Therapeutics Alternatives MIRA Pharmaceuticals Alternatives CEL-SCI Alternatives NanoViricides Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FRTX) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresh Tracks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresh Tracks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FRTX Stock Free FRTX Stock Alerts